Phenylacetylglutamine as a biomarker of healthy aging
A technology of glutamine and phenylacetyl, which is applied in the application field of improvement, can solve the problems such as the comprehensive description of the molecular mechanism that has not yet been reported, and the lack of long-lived metabolic phenotype research.
A technology of glutamine and phenylacetyl, which is applied in the application field of improvement, can solve the problems such as the comprehensive description of the molecular mechanism that has not yet been reported, and the lack of long-lived metabolic phenotype research.
CN104204810BInactive Publication Date: 2017-06-13NESTEC SA
Image
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0136] Subjects and Study Groups
[0137] Each individual and their family gave informed consent for the study to be conducted. In total, in northern Italy (including Bologna, Florence, Parma, Milan), 541 subjects belonging to different age groups were enrolled for this study. The centenarian group consisted of 156 individuals (125 females and 31 males), the older group consisted of 363 individuals (205 females and 158 males), and the young adult group consisted of 22 individuals (10 women and 12 men).
[0138] The study protocol was approved by the ethics committee of the Sant'Orsola-Malpighi University School of Medicine (Bologna, Italy). The resulting biological samples (serum and urine) were stored at -80°C prior to metabolomic analysis.
[0139] clinical chemistry
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
Using NMR / MS-based metabolomics and targeted lipidomics approaches, the inventors studied the metabolic phenotypes of aging and longevity in a cohort including centenarians, older adults, and young adults. The present inventors have identified biomarkers for the reduced risk of developing age-related chronic inflammatory conditions, proposing that the use of phenylacetylglutamine (PAG) as a biomarker diagnosis allows delaying and / or avoiding the life of aging-related chronic inflammatory conditions. way of in vitro methods.
Description
technical field [0001] The present invention generally relates to healthy lifestyles and the prevention of age-related chronic conditions. In particular, the invention relates to biomarkers and their use in detecting lifestyle improvements. Thus, the present invention provides, for example, phenylacetylglutamine (PAG) as a biomarker, and also a method of using the biomarker phenylacetylglutamine to diagnose a lifestyle that allows delaying and / or avoiding aging Associated chronic inflammatory conditions. Background technique [0002] Aging is defined as a time-dependent decline in functional capacity and stress resistance, associated with increased risk of morbidity and mortality. Furthermore, the human aging phenotype is very heterogeneous and can be described as a complex mosaic resulting from the interaction of various environmental, stochastic and genetic-epigenetic variables. Decades of aging research have uncovered hundreds of genes and many biological processes ass...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
13 Jun 2017
Publication
CN104204810B
- IPC
- G01N33/68
- CPC
- G01N33/6893; Y10T436/200833; Y10T436/24; Y10T436/182; G01N2800/60; Y10T436/203332; Y10T436/173845; G01N2800/7095
- Inventors
- S·科里诺; I·蒙托柳 鲁拉